These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30006493)

  • 1. Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.
    Jalal D; Renner B; Laskowski J; Stites E; Cooper J; Valente K; You Z; Perrenoud L; Le Quintrec M; Muhamed I; Christians U; Klawitter J; Lindorfer MA; Taylor RP; Holers VM; Thurman JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
    Kopel T; Kaufman JS; Hamburg N; Sampalis JS; Vita JA; Dember LM
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1588-1594. PubMed ID: 28784655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.
    Downey RM; Liao P; Millson EC; Quyyumi AA; Sher S; Park J
    Am J Physiol Renal Physiol; 2017 May; 312(5):F917-F924. PubMed ID: 28274927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.
    Mörtberg J; Lundwall K; Mobarrez F; Wallén H; Jacobson SH; Spaak J
    BMC Nephrol; 2019 Mar; 20(1):71. PubMed ID: 30823870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis.
    Khaira A; Mahajan S; Kumar A; Saraya A; Tiwari SC; Prakash S; Gupta A; Bhowmik D; Agarwal SK
    Ren Fail; 2011; 33(4):411-7. PubMed ID: 21529270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.
    Ghanavatian S; Diep LM; Bárány P; Heimbürger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
    Angiology; 2014 May; 65(5):443-9. PubMed ID: 23567479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Endothelial Dysfunction and Prevalence of Chronic Kidney Disease: The Circulatory Risk in Communities Study (CIRCS).
    Li Y; Cui R; Liu K; Eshak ES; Cui M; Dong J; Imano H; Muraki I; Kiyama M; Kitamura A; Okada T; Yamagishi K; Umesawa M; Ohira T; Iso H;
    J Atheroscler Thromb; 2021 Jun; 28(6):622-629. PubMed ID: 32879150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction and complement activation are independently associated with disease duration in patients with systemic vasculitis.
    Dolgyras P; Anyfanti P; Lazaridis A; Gavriilaki E; Koletsos N; Triantafyllou A; Barbara N; Mastrogiannis K; Yiannaki E; Papakonstantinou A; Galanapoulou V; Douma S; Gkaliagkousi E
    Microvasc Res; 2024 Jul; 154():104692. PubMed ID: 38705254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipients.
    Memon L; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kotur-Stevuljevic J; Simic-Ogrizovic S; Giga V; Dopsaj V; Jelic-Ivanovic Z; Spasic S
    Dis Markers; 2013; 35(3):173-80. PubMed ID: 24167363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F
    Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
    Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
    Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang QY; Jiang CM; Sun C; Tang TF; Jin B; Cao DW; He JS; Zhang M
    J Nephrol; 2015 Aug; 28(4):471-6. PubMed ID: 25515034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial and kidney function in women with a history of preeclampsia and healthy parous controls: A case control study.
    Lopes van Balen VA; Spaan JJ; Cornelis T; Heidema WM; Scholten RR; Spaanderman MEA
    Microvasc Res; 2018 Mar; 116():71-76. PubMed ID: 29126987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between serum cathepsin D levels and endothelial dysfunction in patients with chronic kidney disease.
    Ozkayar N; Piskinpasa S; Akyel F; Turgut D; Bulut M; Turhan T; Dede F
    Nefrologia; 2015; 35(1):72-9. PubMed ID: 25611836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.
    Gimblet CJ; Kruse NT; Geasland K; Michelson J; Sun M; Mandukhail SR; Wendt LH; Eyck PT; Pierce GL; Jalal DI
    Clin J Am Soc Nephrol; 2024 Feb; 19(2):161-168. PubMed ID: 37843843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Dysfunction by Flow-Mediated Vasodilatation in Chronic Kidney Disease.
    Shukla V; Dey R; Chandra A; Karoli R; Khanduri S
    J Assoc Physicians India; 2015 Jun; 63(6):30-3. PubMed ID: 26710397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease.
    Keskin GS; Helvacı Ö; Yayla Ç; Paşaoğlu Ö; Keskin Ç; Arınsoy T; Derici Ü
    Turk J Med Sci; 2019 Feb; 49(1):139-146. PubMed ID: 30763987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renalase Assessment With Regard to Kidney Function, Lipid Disturbances, and Endothelial Dysfunction Parameters in Stable Renal Transplant Recipients.
    Stojanovic D; Cvetkovic T; Stojanovic M; Stefanovic N; Velickovic-Radovanovic R; Zivkovic N
    Prog Transplant; 2017 Jun; 27(2):125-130. PubMed ID: 28617168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.
    Parker B; Al-Husain A; Pemberton P; Yates AP; Ho P; Gorodkin R; Teh LS; Alexander MY; Bruce IN
    Ann Rheum Dis; 2014 Jun; 73(6):1144-50. PubMed ID: 23644670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.